MktsMarkets

Greenwich LifeSciences, Inc.
NASDAQ: GLSIKey statistics
GLSI News
Stories mentioning GLSI from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | 5,208 | 8,266 | 3,267 | 3,416 | 2,271 | 8,685 | 2,292 | 2,308 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 5,726 | 9,176 | 3,734 | 3,769 | 2,769 | 9,710 | 2,729 | 2,661 |
| Operating Income (Loss) | (5,726) | (8,458) | (4,175) | (4,046) | (2,769) | (9,710) | (2,729) | (2,661) |
| Interest Income | 69.00 | 22.00 | 23.00 | 21.00 | 24.00 | 44.00 | 60.00 | 55.00 |
| Interest Expense | ||||||||
| Other Expense | ||||||||
| Pretax Income | ||||||||
| Tax Provision | ||||||||
| Net Income (Loss) | (5,657) | (9,153) | (3,711) | (3,749) | (2,745) | (9,665) | (2,669) | (2,607) |
| Earnings Per Share (Basic) | (0.39) | (0.68) | (0.27) | (0.28) | (0.21) | (0.74) | (0.20) | (0.20) |
| Earnings Per Share (Diluted) | (0.39) | (0.68) | (0.27) | (0.28) | (0.21) | (0.74) | (0.20) | (0.20) |
| Weighted Average Shares Outstanding (Basic) | 14,565 | 13,535 | 13,641 | 13,371 | 13,172 | 13,015 | 13,142 | 12,907 |
| Weighted Average Shares Outstanding (Diluted) | 14,565 | 13,535 | 13,641 | 13,371 | 13,172 | 13,015 | 13,142 | 12,907 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About GLSI
Greenwich LifeSciences, Inc. (NASDAQ: GLSI) is a stock listed on the Nasdaq Stock Market under the ticker symbol GLSI. It last traded at $14.94 (Nov 13, 2026, 4:00 PM ET), down 2.2% on the day. That gives Greenwich LifeSciences a market capitalisation of $219.3M.
Over the past 52 weeks GLSI has traded between $7.78 and $34.10.
For the quarter ended Mar 31, 2026 it reported a net loss of $5.7M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$5.7M |
| Dec 31, 2025 | — | -$9.2M |
| Sep 30, 2025 | — | -$3.7M |
| Jun 30, 2025 | — | -$3.7M |
From Greenwich LifeSciences’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…